Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children
Open Access
- 1 November 2020
- Vol. 38 (50) , 7977-7988
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled TrialPLOS ONE, 2013
- Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trialTrials, 2013
- Salivary Immune Responses to the 7-Valent Pneumococcal Conjugate Vaccine in the First 2 Years of LifePLOS ONE, 2012
- Pneumococcal Conjugate Vaccine Given Shortly After Birth Stimulates Effective Antibody Concentrations and Primes Immunological Memory for Sustained Infant ProtectionClinical Infectious Diseases, 2011
- Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell toleranceVaccine, 2011
- Serotype-Specific Hyporesponsiveness to Pneumococcal Conjugate Vaccine in Infants Carrying Pneumococcus at the Time of VaccinationThe Journal of Pediatrics, 2010
- Nasopharyngeal Carriage ofStreptococcus pneumoniaeShortly before Vaccination with a Pneumococcal Conjugate Vaccine Causes Serotype‐Specific Hyporesponsiveness in Early InfancyThe Journal of Infectious Diseases, 2010
- Impact of the Molecular Form of Immunoglobulin A on Functional Activity in Defense againstStreptococcus pneumoniaeInfection and Immunity, 2007
- Development of mucosal immunity in the first year of life and relationship to sudden infant death syndromeFEMS Immunology & Medical Microbiology, 2004
- Primary and Booster Salivary Antibody Responses to a 7‐Valent Pneumococcal Conjugate Vaccine in InfantsThe Journal of Infectious Diseases, 2000